These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20012624)

  • 21. The association between oxidized low-density lipoprotein antibodies and hematological diseases.
    Li H; Li DQ; Li XX; Wang LQ
    Lipids Health Dis; 2016 Nov; 15(1):190. PubMed ID: 27825356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease.
    Rouhl RP; van Oostenbrugge RJ; Theunissen RO; Knottnerus IL; Staals J; Henskens LH; Kroon AA; de Leeuw PW; Lodder J; Tervaert JW; Damoiseaux JG
    Stroke; 2010 Nov; 41(11):2687-9. PubMed ID: 20947847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
    Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
    Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
    Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
    Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
    Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
    Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers.
    van Tits LJ; de Waart F; Hak-Lemmers HL; van Heijst P; de Graaf J; Demacker PN; Stalenhoef AF
    Free Radic Biol Med; 2001 May; 30(10):1122-9. PubMed ID: 11369502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against oxLDL and acute coronary syndrome.
    Medeiros AM; von Mühlen CA; Gidlund MA; Bodanese R; Gottlieb MG; Bodanese LC
    Arq Bras Cardiol; 2010 Jul; 95(1):47-54. PubMed ID: 20563523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
    Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
    J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
    Virella G; Carter RE; Saad A; Crosswell EG; Game BA; ; Lopes-Virella MF
    Clin Immunol; 2008 Jun; 127(3):394-400. PubMed ID: 18533284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
    Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
    Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auto-Antibody Production During Experimental Atherosclerosis in
    Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
    Front Immunol; 2021; 12():695220. PubMed ID: 34305930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
    Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.